Pharma Stocks
-
CorMedix vs. Mirum Pharma: Which Rare-Disease Stock is the Better Buy? – January 20, 2026
Key Takeaways Mirum Pharmaceuticals shows a clearer growth narrative with multiple revenue drivers beyond Livmarli. CRMD’s outlook is clouded by…
Read More » -
Which Pharma Stock Stands Taller Right Now: LLY or PFE? – January 20, 2026
Key Takeaways LLY’s Mounjaro and Zepbound are driving strong sales growth, with demand expected to remain high in 2026. Lilly…
Read More » -
Piramal Pharma Ltd Stock Hits 52-Week Low at Rs.160.85 Am…
Recent Price Movement and Market Context On 20 Jan 2026, Piramal Pharma Ltd’s stock touched an intraday low of Rs.160.85,…
Read More » -
Torrent Pharmaceuticals Ltd. Hits New 52-Week High at Rs …
Strong Momentum Drives Stock to New Heights The pharmaceutical giant’s shares demonstrated robust momentum, closing just 0.1% shy of the…
Read More » -
The Quiet Pharma Tech Power Move Wall Street Is Sleeping On
Everyone’s chasing meme stocks while Certara Inc quietly powers the drug brands you actually use. Is CERT the next under-the-radar…
Read More » -
Mankind Pharma Limited’s (NSE:MANKIND) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
It is hard to get excited after looking at Mankind Pharma’s (NSE:MANKIND) recent performance, when its stock has declined 11%…
Read More » -
Is Amylyx Pharmaceuticals’ (AMLX) New GLP-1 Rare Disease Bet Expanding or Diluting Its Core Strategy?
Earlier in January 2026, Amylyx Pharmaceuticals announced it had selected AMX0318, a long-acting GLP-1 receptor antagonist discovered with Gubra A/S,…
Read More » -
Assessing IDEAYA Biosciences (IDYA) Valuation After Bullish Analyst Reports And Big Pharma Partnerships
IDEAYA Biosciences (IDYA) is back in focus after a cluster of upbeat analyst reports highlighted its precision oncology pipeline and…
Read More » -
Is Jazz (JAZZ) Quietly Recasting Its Oncology Strategy Through HER2 Partnerships And Voucher Monetization?
In recent days, Boehringer Ingelheim announced a clinical collaboration with Jazz Pharmaceuticals to test a combination of zongertinib and Jazz’s…
Read More » -
Takeda Pharmaceutical (TSE:4502) Valuation Check After Recent Share Price Momentum
Why Takeda Pharmaceutical Stock Is On Investors’ Radar Takeda Pharmaceutical (TSE:4502) has recently drawn attention after a strong run in…
Read More »